Vivos (RDGL) Liabilities and Shareholders Equity (2010 - 2025)

Vivos (RDGL) reported Liabilities and Shareholders Equity of $1.9 million for Q4 2025, down 16.38% on a YoY basis from $2.2 million in Q4 2024, and down 18.63% sequentially from $2.3 million in Q3 2025.

Vivos (RDGL) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends

Vivos (RDGL) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $1.9 million in Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 16.38% year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2025 stood at $10.2 million (up 54.46% YoY), and the FY2025 full-year result was $1.9 million, down 16.38% from the prior year.
  • Liabilities and Shareholders Equity declined to $1.9 million in Q4 2025, from $2.3 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $3.3 million in Q1 2025 to a low of $1.1 million in Q2 2022.
  • A 5-year average of $1.9 million and a median of $1.8 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity surged 3429.68% in 2021 and sank 50.37% in 2022, its largest moves.
  • Tracing RDGL's Liabilities and Shareholders Equity over 5 years: stood at $1.6 million in 2021, then increased by 6.64% to $1.7 million in 2022, then decreased by 7.61% to $1.6 million in 2023, then surged by 38.71% to $2.2 million in 2024, then fell by 16.38% to $1.9 million in 2025.
  • Business Quant data shows RDGL's Liabilities and Shareholders Equity at $1.9 million in Q4 2025, $2.3 million in Q3 2025, and $2.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 46.29 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 13.32 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 37.13 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - 10.46 Bn
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 31.92 Bn
10 Vivos 27.16 Mn 25.60 Mn -3,105.00 1.87 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.87 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 2.78 Mn
Mar 31, 2025 3.30 Mn
Dec 31, 2024 2.23 Mn
Sep 30, 2024 1.24 Mn
Jun 30, 2024 1.77 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 1.61 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.79 Mn
Mar 31, 2023 1.46 Mn
Dec 31, 2022 1.74 Mn
Sep 30, 2022 2.05 Mn
Jun 30, 2022 1.11 Mn
Mar 31, 2022 1.31 Mn
Dec 31, 2021 1.63 Mn
Sep 30, 2021 2.04 Mn
Jun 30, 2021 2.23 Mn
Mar 31, 2021 2.52 Mn